We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sen. Grassley Questions FDA on Impact of Investigator Financial Conflicts
Sen. Grassley Questions FDA on Impact of Investigator Financial Conflicts
October 27, 2010
Findings from an ongoing Senate inquiry on clinical trial practices have led Sen. Chuck Grassley (R-Iowa) to ask FDA Commissioner Margaret Hamburg if there are financial interests that the FDA would consider too significant for a clinical investigator to be involved in a study.